Bioforce Nanosciences Holdings, Inc. (BFNH) Stock Forecast Oct. 16, 2026

Our AI ranks Bioforce Nanosciences Holdings, Inc. outside the neutral middle of its coverage (a directional signal). Create a free account and follow it to see the exact price target.

Bioforce Nanosciences Holdings, Inc. is a small-cap company with a market capitalization of $235M. It ranks number 16 by market capitalization among the 25 Laboratory Analytical Instruments issuers in our coverage with a current forecast. Its P/B Ratio of 101.81x is the highest of the 23 peers that report one. Its Current Ratio of 25.41x is the highest of the 25 peers that report one.

For BFNH, the Spearman rank correlation between our 90-day forecasts and the returns that followed is -27.0%, measured on 357 forecast dates between 2022-07-29 and 2026-07-17 on this stock's own recent history. A rank correlation runs from -100% to +100%: it measures whether higher forecasts were followed by higher returns, and a value near zero or below means the model has shown little skill on this stock. On the 30-day forecasts the same correlation is -10.0%, measured on 400 forecast dates between 2022-07-29 and 2026-09-16. Across our coverage, the out-of-sample test on 4495 stocks from 2025-01-06 to 2026-07-07 produced a positive net return in 82.5% of rebalance periods (factor-neutral book, net of estimated costs). Full backtest report

Expected return relative to the market over the horizon: a positive alpha means the model expects the stock to beat the market, whatever the market does. Ratings: strong buy ≥ +1.8%, buy ≥ +0.2%, sell < -0.9%, strong sell < -1.2% (top 15%, next 20%, middle 30%, next 20%, bottom 15% of the 2026-10-16 signals)

All daily signals →